Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
STOCKHOLM, Sweden, July 1, 2002 (PRIMEZONE) -- Biovitrum and Octapharma today announced that an agreement has been signed under which Octapharma will acquire Biovitrum's Plasma Products...
-
STOCKHOLM, Sweden, March 11, 2002 (PRIMEZONE) -- Biovitrum (LSE:BIO) today announced that it has entered Phase I studies with BVT.3498, a selective 11B HSD-1 inhibitor for the treatment of Type II...
-
STOCKHOLM, Sweden, Feb. 27, 2002 (PRIMEZONE) -- Biovitrum today announced the positive results of a phase IIa trial for its anti-obesity treatment BVT.933. "We are delighted to have achieved Proof...